Home > Specialists > Medical Oncology > Dr. Jun Cao (曹君)
Specialty & Clinical Focus:
Medical oncology specialist at Fudan University Shanghai Cancer Center in Shanghai, with a clinical focus on comprehensive breast cancer management, chemotherapy, targeted therapy, immunotherapy, innovative anti-tumor drugs, and personalized molecularly targeted treatment.
Professional Title & Qualifications:
-
Associate Chief Physician,
-
MD/PhD Candidate
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Medical Oncology
(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)
Dr. Jun Cao (曹君) - Medical Oncology Specialist
Personal Biography
Dr. Jun Cao is an Associate Chief Physician in the Department of Medical Oncology at Fudan University Shanghai Cancer Center (FUSCC), where she has practiced since 2007. Her clinical focus is the comprehensive medical management of malignant tumors, particularly breast cancer, including chemotherapy, targeted therapy, and immunotherapy. She completed Fudan University Shanghai Medical College’s seven-year clinical medicine program in 2007 with a Master’s degree in Oncology and is currently pursuing a PhD in the same field. Her background also includes regulatory drug review and clinical research involving innovative anti-tumor therapies.
Why Consider Dr. Jun Cao for Your Care?
Dr. Jun Cao has practiced at Fudan University Shanghai Cancer Center since 2007, with a clinical focus on comprehensive breast cancer management, including chemotherapy, targeted therapy, immunotherapy, and personalized molecular targeted therapy.
Her experience extends beyond routine clinical practice to the research and clinical application of innovative anti-tumor drugs. Dr. Cao has participated as a sub-investigator in more than 100 Phase II and III international and domestic multicenter clinical trials and previously served as a visiting reviewer at the Center for Drug Evaluation of China’s National Medical Products Administration.
Her listed honors also include a First Prize of the Shanghai Medical Science and Technology Award for work on integrated treatment strategies for recurrent and metastatic breast cancer. For international patients comparing treatment pathways in China, this combination of breast cancer practice, drug-development experience, and clinical research can make a remote specialist review a useful step before planning travel to Shanghai.
Pre-Travel Case Review & Specialist Liaison
Considering breast cancer care in China often requires reviewing medical records and treatment history before international travel. Through MedBridgeNZ, patients can request coordination for a remote specialist review with Dr. Cao. We coordinate medical-record preparation, translation where needed, client-authorized document transfer, and appointment communication with the relevant specialist office.
As part of the arranged review pathway, Dr. Cao will review the submitted records, provide her specialist opinion and recommendations, and address the questions submitted with the case. This gives patients a clearer basis for deciding whether to proceed with an in-person care pathway in Shanghai and for planning the next administrative and travel steps.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Jun Cao
Areas of Expertise
Comprehensive medical treatment of breast cancer.
Chemotherapy, targeted therapy, and immunotherapy for malignant tumors.
Clinical research and application of innovative anti-tumor drugs.
Molecular targeted therapy and personalized cancer management.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
4,100 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
2007 – Present: Associate Chief Physician/Attending Physician, Department of Medical Oncology, Fudan University Shanghai Cancer Center.
2018: Visiting Reviewer, Center for Drug Evaluation (CDE), National Medical Products Administration (NMPA/formerly CFDA).
2017: Participant in the "Targeted Poverty Alleviation" medical mission in Yunnan, organized by the Shanghai Municipal Health Commission.
Education & Training
2007: Graduated from the 7-year clinical medicine program at Fudan University Shanghai Medical College with a Master’s degree in Oncology.
Currently pursuing a PhD in Oncology.
Awards & Honors
First Prize, Shanghai Medical Science and Technology Award (for the project: "Optimization and Promotion of Integrated Treatment Strategies for Recurrent and Metastatic Breast Cancer").
First Prize, National Maternal and Child Health Science and Technology Award.
Outstanding Contribution Award for Targeted Support, Fudan University Shanghai Cancer Center (2017).
Academic & Professional Memberships
Member, Yangtze River Breast Cancer Group (YBCSG).
Youth Member, Breast Cancer Professional Committee of the Shanghai Anti-Cancer Association.
Member, Clinical Research Professional Committee of the Shanghai Anti-Cancer Association.
Member, Cancer Rehabilitation and Palliative Care Committee of the Shanghai Anti-Cancer Association.
Peer Reviewer, Chinese Journal of Cancer.
Research & Publications
Clinical Trials: Participated as a sub-investigator in over 100 Phase II/III international and domestic multi-center clinical trials.
Publications: Published over 20 research papers indexed in SCI.
Book Authorship: Contributed to over 10 professional medical texts, including Q&A on Common Clinical Issues in Oncology, Breast Tumor Therapeutics, Handbook of Medical Oncology Treatment, and Handbook of Chemotherapy Regimens in Medical Oncology.
Research Projects: Principal Investigator for a precision diagnosis and treatment project for thoracic and abdominal tumors under the Wu Jieping Medical Foundation.
Selected Peer-Reviewed Publications
Cao J et al. Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial. BMC Med. 2023;21(1):300. PMID: 37559142
Cao J et al. Phase 1b clinical trial of pucotenlimab (HX008) combined with gemcitabine and cisplatin in first-line metastatic triple-negative breast cancer. Front Oncol. 2022;12:837963. PMID: 35982961
Li T, Cao J, et al. Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study). J Clin Oncol. 2026. PMID: 41779972
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Cao the right specialist for my specific type of breast cancer?
Dr. Cao’s clinical focus includes comprehensive medical treatment of breast cancer, including chemotherapy, targeted therapy, immunotherapy, and personalized molecular targeted therapy. For a specific case, MedBridgeNZ can coordinate a remote specialist review by preparing and transferring your records and questions to the specialist office. Dr. Cao will review the submitted material and provide her opinion and recommendations, helping you understand whether an in-person care pathway in Shanghai is worth considering.
How can I book an appointment with Dr. Cao as an international patient?
International patients can start by requesting remote specialist-review coordination through MedBridgeNZ. We coordinate medical-record preparation, translation where needed, client-authorized document transfer, and appointment communication. If you decide to travel to Shanghai after the review, we can also assist with hospital appointment requests, medical invitation or visa-document coordination, travel planning, and non-clinical bilingual administrative support. Appointment timing and onsite arrangements are coordinated with the relevant hospital or specialist office.
Can I access advanced therapies or clinical trials through this specialist?
Dr. Cao has participated as a sub-investigator in more than 100 Phase II and III multicenter clinical trials and has experience with the clinical research and application of innovative anti-tumor drugs. During a remote specialist review, you can ask whether there are advanced treatment approaches or clinical-trial pathways relevant to your case. Trial participation or treatment eligibility depends on the hospital’s current protocols and the specialist or research team’s clinical assessment; MedBridgeNZ can coordinate the related records and communication.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients considering specialist care in China. We help coordinate remote specialist-review requests, medical-record preparation, translation, appointment requests, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative support. Our role is to make the cross-border process more organized before and during travel. We do not provide medical advice, diagnosis, or treatment. Any hospital, specialist, or other third-party charges remain separate unless expressly stated in writing.